###begin article-title 0
Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 270 275 <span type="species:ncbi:9606">human</span>
The cytokine transforming growth factor-beta (TGF-beta), and the ED-A splice variant of the extracellular matrix protein fibronectin modulate wound healing and scar formation. To further elucidate their possible role in filtering bleb scarring after glaucoma surgery in human eyes in vivo, we studied the cell type specific localization of TGF-beta receptors and the presence of ED-A fibronectin in sections of normal conjunctiva and scarred filtering blebs.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Cryosections of normal conjunctiva (four patients) and scarred filtering blebs (seven patients) were studied by double-label immunofluorescence. Antibodies against PECAM-1 and prolyl-4-hydroxylase allowed for specification of vascular endothelial cells and activated fibroblasts, respectively. TGF-beta receptor type II (TGF-beta-RII), alpha-smooth muscle actin, O-linked sialoglycoprotein, fibronectin and the ED-A fibronectin splice-variant were also detected using specific antibodies. Labeled sections were viewed with a confocal laser scanning microscope.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
Vascular endothelial cells expressed TGF-beta-RII in both normal and scarred tissue. TGF-beta-RII was sparsely detected in the fibroblasts of normal conjunctiva while it was strongly expressed in most fibroblasts of the scarred filtering blebs. Similarly, ED-A fibronectin was not detected in the extracellular matrix of normal conjunctiva but abundantly present in scarred filtering blebs.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Filtering bleb scarring is associated with an abundant expression of TGF-beta receptors in activated fibroblasts and the deposition of the fibrogenic ED-A fibronectin splice-variant. These data support the concept of targeting TGF-beta signaling to prevent scar formation after filtering glaucoma surgery.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 298 299 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 300 301 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 365 366 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 367 368 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 521 522 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 523 524 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 639 640 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 764 765 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 934 935 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
###xml 750 756 <span type="species:ncbi:9986">rabbit</span>
Scar formation is the most frequent cause of failure following glaucoma filtering surgery, but the pathophysiological mechanisms of filtering bleb scarring are not fully elucidated. The cytokine transforming growth factor-beta (TGF-beta), is pivotal in wound healing and scar formation in general [1,2]. All three TGF-beta isoforms have been identified in the eye [3,4] with TGF-beta-2 being the predominant isoform associated with ocular scarring diseases such as proliferative vitreoretinopathy and cataract formation [5,6]. In a mouse model of conjunctival scarring, TGF-beta-2 was strongly expressed in the stroma of the wounded area [7] and a TGF-beta-2-specific neutralizing antibody prevented conjunctival scarring after glaucoma surgery in a rabbit model [8]. However, a recent phase III clinical trial failed to demonstrate a significant effect of TGF-beta-2-specific antibodies in the prevention of filtering bleb scarring [9] and raised some reservations concerning the targeting of TGF-beta.
###end p 11
###begin p 12
###xml 82 84 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
In the early phases of wound healing, TGF-beta is secreted by inflammatory cells [10] and acts as a chemoattractant. In the long-term, TGF-beta promotes the transdifferentiation of fibroblasts to highly contractile myofibroblasts, which deposit extracellular matrix proteins and serve as the main agents of scarring if present persistently. TGF-beta binds to a heterodimeric receptor complex, consisting of two serine-threonine kinase receptors designated TGF-beta type I and II receptor, and leads to the activation of several intracellular signaling pathways. The tissue distribution of TGF-beta receptor-bearing cells in normal conjunctiva and scarred filtering blebs is currently unclear.
###end p 12
###begin p 13
###xml 166 168 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 403 405 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Furthermore, scarring is associated with alterations in the extracellular matrix composition. TGF-beta induces the expression of the ED-A fibronectin splice variant [11] as a precondition for TGF-beta-mediated myofibroblast transdifferentiation. Studies in vitro revealed that TGF-beta-induced myofibroblast transdifferentiation was averted by the blocking of ED-A fibronectin with specific antibodies [11]. The role of ED-A fibronectin in filtering bleb scarring has not been addressed.
###end p 13
###begin p 14
###xml 89 94 <span type="species:ncbi:9606">human</span>
To gain further insight into the possible role of TGF-beta in filtering bleb scarring in human eyes in vivo, we studied the cell type-specific distribution of TGF-beta-RII and the presence of ED-A fibronectin in normal conjunctiva and scarred filtering blebs.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Tissue samples
###end title 16
###begin p 17
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Conjunctival specimens were obtained during standard intraocular surgery after comprehensive information and written consent of the selected patients. The tenets of the Declaration of Helsinki were followed, and an institutional ethics committee approval had been granted. Native conjunctival tissue was gained from four patients undergoing strabismus surgery while hypertrophic scar tissue was obtained from seven patients undergoing filtering bleb revision surgery after multiple preceding operations (Table 1). All specimens were embedded in Tissue Tek cryopreservant and snap frozen in liquid nitrogen.
###end p 17
###begin title 18
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end title 18
###begin p 19
###xml 10 17 <span type="species:ncbi:9606">patient</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
Survey of patient characteristics including age, sex, reason for surgery (strabismus surgery or glaucoma surgery), type of glaucoma, number and time after previous surgery, history of topical medication. All patients undergoing revision glaucoma surgery received topical mitomycin C treatment. Abbreviations: POAG: primary open angel glaucoma; PEX: pseudoexfoliation glaucoma.
###end p 19
###begin title 20
Tissue processing and immunofluorescent staining
###end title 20
###begin p 21
###xml 36 42 <span type="species:ncbi:9986">rabbit</span>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 834 838 <span type="species:ncbi:9925">goat</span>
The following antibodies were used: rabbit anti-TGF-beta-RII (L-21, Santa Cruz Biotechnology, Santa Cruz, CA), and monoclonal mouse anti-PECAM-1 (DAKO, Glostrup, Denmark) to detect vascular endothelial cells; anti-alpha-SMA, anti-FN, anti-ED-A-FN (Sigma, St.Louis, MO), and anti-O-linked sialoglycoprotein (D2-40, Signet Laboratories, Dedham) to detect lymphatic endothelium; and mouse anti-prolyl-4-hydroxylase (DAKO) directed against an enzyme involved in posttranslational collagen modification to detect activated fibroblasts. Secondary antibodies were labeled with Alexa-488 or Alexa-568 (Molecular Probes, Leiden, The Netherlands). Cryostat sections of 6 microm thickness were prepared, air dried, fixed in pure acetone for 20 min at -20 degreesC, and blocked for 1 h in TRIS buffered saline (TBS, pH 7.6), containing 4% normal goat serum (NGS, Dianova, Hamburg, Germany). Antibodies were diluted in TBS, containing 1% NGS plus 0.1% Triton X-100. The primary antibodies were incubated overnight at 4 degreesC in a humidified chamber. Secondary antibodies were applied sequentially for 1 h at room temperature. Following each incubation, the specimens were washed three times in TBS and finally mounted in Vectashield (Vector, Burlingame, CA). The stained slides were viewed with a laser scanning confocal microscope (TCS SP-2, Leica, Bensheim, Germany).
###end p 21
###begin p 22
###xml 71 72 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 225 226 225 226 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Increased cell density in scarred filtering blebs. Normal conjunctiva (A) shows loose subepithelial connective tissue with sparse fibroblasts and occasional vascular structures (arrows). In contrast, scarred filtering blebs (B) are characterized by compacted connective tissue with abundant spindle-shaped cells and various vascular structures. H&E stains.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
Increased cell density in scarred filtering blebs
###end title 24
###begin p 25
###xml 119 128 119 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
In normal conjunctiva, the subepithelial stroma contained sparse fibroblasts and occasional small vascular structures (Figure 1A, arrows). Specimens of scarred filtering blebs showed a high density of spindle-shaped cells, presumably fibroblasts, several vascular structures, and areas of inflammatory cell infiltrates (Figure 1B). Only one scar specimen and all normal specimens contained an epithelial layer. To avoid leakage and allow for proper wound closure after revision surgery, care was taken to spare the conjunctival epithelial layer, which explains the absence of epithelium in most scar specimens.
###end p 25
###begin p 26
###xml 64 65 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 105 106 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 108 109 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 213 214 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 245 246 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 421 422 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 424 425 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 442 443 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Colocalization of TGF-beta-RII and PECAM-1. Native conjunctiva (A) and scarred filtering bleb specimens (B, C) were double-stained for TGF-beta-RII (green) and the vascular endothelial cell marker, PECAM-1 (red). C is a close-up of a section of B as indicated by the frame. Arrows point to elongated TGF-beta-RII positive cells devoid of PECAM-1 signal, which are most likely fibroblasts. Scale bar represents 50 microm (A, B) and 10 microm (C).
###end p 26
###begin p 27
###xml 99 100 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 140 141 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 143 144 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 223 224 217 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 255 256 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 435 436 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 437 438 421 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 455 456 435 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Colocalization of TGF-beta-RII and the fibroblast marker prolyl-4-hydroxylase. Native conjunctiva (A) and scarred filtering bleb specimens (B, C) were double-stained for TGF-beta-RII (green) and prolyl-4-hydroxylase (red). C is a close-up of a portion of B as indicated by the frame. Arrows point to a TGF-beta-RII positive fibroblast, which are positive for both TGF-beta-RII and prolyl-4-hydroxylase. Scale bar represents 50 microm (A,B) and 10 microm (C).
###end p 27
###begin title 28
TGF-beta receptor II expression in native conjunctiva and scarred filtering blebs
###end title 28
###begin p 29
###xml 365 374 356 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 411 424 402 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A,B,C</xref>
###xml 626 635 614 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 640 649 628 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
To assess TGF-beta receptor expression and identify TGF-beta-responsive cell types, immunofluorescent double stains were performed. Vascular endothelial cells were stained with an antibody recognizing PECAM-1, and activated fibroblasts were detected using an antibody against the enzyme prolyl-4-hydroxylase. TGF-beta-RII expression was strong in epithelial cells (Figure 2A) and in vascular endothelial cells (Figure 2A,B,C). Activated, prolyl-4-hydroxylase-positive fibroblasts were absent in normal conjunctiva, and a faint staining for TGF-beta-RII was rarely seen in non-vascular areas of the normal conjunctival stroma (Figure 2A and Figure 3A).
###end p 29
###begin p 30
###xml 103 114 103 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B,C</xref>
###xml 166 177 163 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B,C</xref>
###xml 254 263 251 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 374 385 371 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B,C</xref>
###xml 483 494 477 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B,C</xref>
###xml 571 582 561 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B,C</xref>
###xml 675 686 665 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4E,F</xref>
Specimens of scarred filtering blebs were rich in vascular structures as detected by PECAM-1 staining (Figure 2B,C). PECAM-1 positive cells stained for TGF-beta-RII (Figure 2B,C), but non-vascular spindle-shaped cells were also expressing this receptor (Figure 2C, arrows). The latter appear to be activated fibroblasts as detected by an anti-prolyl-4-hydroxylase antibody (Figure 3B,C). These cells were abundant in scarred filtering blebs, and most of them expressed TGF-beta-RII (Figure 3B,C, arrows). In scarred filtering blebs, fibroblasts also expressed alpha-SMA (Figure 4B,C), which was detected in perivascular cells as well. Lymphatic endothelium was not detected (Figure 4E,F).
###end p 30
###begin p 31
###xml 127 133 <span type="species:ncbi:9986">rabbit</span>
No staining was observed when the anti-TGF-beta-RII antibody was preadsorbed to a specific control peptide, or when non-immune rabbit IgG was used as a primary antibody as well as when primary antibodies were omitted (data not shown).
###end p 31
###begin title 32
Fibronectin and ED-A fibronectin in native conjunctiva and scarred filtering blebs
###end title 32
###begin p 33
###xml 307 318 307 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5A,B</xref>
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5A</xref>
###xml 563 572 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5B</xref>
To study fibronectin extracellular matrix composition in conjunctival tissue, we performed double stains using antibodies against total fibronectin and the ED-A fibronectin splice variant. Fibronectin was found throughout the subepithelial stroma in both the normal conjunctiva and scarred filtering blebs (Figure 5A,B). In normal conjunctiva, expression of the ED-A fibronectin splice variant was restricted to perivascular areas and basal epithelial cells (Figure 5A). In contrast, ED-A fibronectin was present throughout the stroma of scarred filtering blebs (Figure 5B).
###end p 33
###begin p 34
###xml 177 178 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 180 181 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 187 189 180 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G;</bold>
###xml 212 213 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 215 216 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 247 248 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 250 251 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 267 268 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 270 271 259 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 367 368 349 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 369 370 351 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 371 372 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 419 420 398 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 474 475 453 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 545 546 524 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 548 549 527 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 551 552 530 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
Localization of alpha-smooth muscle actin (SMA) and the absence of lymphatic endothelium in scarred filtering bleb tissue. Serial sections were double labeled for TGF-beta-RII (A, D, and G; green) and alpha-SMA (B, C), O-linked sialoglycoprotein (E, F), and PECAM-1 (H, I, red). alpha-SMA is colocalized to TGF-beta-RII in stromal fibroblasts and perivascular cells (A,B,C). Vascular structures expressing TGF-beta-RII(H) were negative for markers of lymphatic endothelium (E).Some collagen fiber autofluorescence is present in the red channel (B, E, H), Scale bar represents 50 microm.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 302 304 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 305 307 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
Scar formation remains a serious problem following filtering glaucoma surgery. The cytokine TGF-beta, promotes the transdifferentiation of human tenon fibroblasts to myofibroblasts in vitro and has been detected in conjunctival epithelium and subepithelial extracellular matrix after glaucoma surgery [12,13]. However, data on the localization of the respective TGF-beta receptors in conjunctival tissue have been lacking. A recent phase III clinical trial, which failed to show an advantage of a topical administered antibody against TGF-beta-2 over placebo has raised some reservations regarding the effectiveness of TGF-beta-antagonizing strategies to prevent filtering bleb scarring. To further address the relevance of TGF-beta in human filtering bleb scarring in vivo, we assessed the cell type-specific localization of TGF-beta receptors in normal conjunctiva and scarred filtering blebs. Furthermore, we examined the distribution of ED-A fibronectin as an indicator for TGF-beta-induced extracellular matrix alterations.
###end p 36
###begin p 37
###xml 226 228 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 295 297 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 691 693 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 694 696 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 794 796 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 465 480 <span type="species:ncbi:10090">Transgenic mice</span>
TGF-beta receptors were detected in conjunctival epithelial cells and in vascular endothelial cells of both the normal conjunctiva and scarred filtering blebs. This is consistent with studies of cutaneous squamous epithelium [14] where TGF-beta exerts homeostatic and antiproliferative effects [15]. The significance of TGF-beta in angiogenesis is also well established although the exact effects of TGF-beta on vascular endothelial cells have not fully unraveled. Transgenic mice deficient in TGF-beta-1, TGF-beta receptor 1 (ALK1), TGF-beta receptor 2 (ALK4), or the accessory TGF-beta-binding protein endoglin, suffer from defects in angiogenesis and vascular malformations (reviewed in [16,17]). An increase in vascularity is an important clinical sign of impending filtering bleb failure [18].
###end p 37
###begin p 38
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 286 287 286 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Expression of fibronectin and the ED-A fibronectin splice variant. Fibronectin is abundant in normal conjunctiva (A) and in scarred filtering blebs (B). In contrast, expression of the fibrogenic ED-A fibronectin splice variant is restricted to perivascular areas in normal conjunctiva (A), but expands throughout the tissue in scarred filtering blebs (B). Specimens were double-stained for total fibronectin (green) and the fibronectin isoform, ED-A (red). Scale bar represents 50 microm.
###end p 38
###begin p 39
###xml 839 841 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 842 844 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 956 958 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1018 1020 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1116 1118 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1425 1427 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1583 1585 1541 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 2187 2188 2136 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1337 1342 <span type="species:ncbi:9606">Human</span>
Most importantly, we provide evidence for a substantially different distribution of TGF-beta receptors and ED-A fibronectin in the connective tissue of the normal conjunctiva and scarred filtering blebs. As detected by immunofluorescence, TGF-beta receptors were virtually absent in fibroblasts of normal conjunctiva while they were abundant and strongly expressed in activated fibroblasts of scarred filtering blebs. Similarly, ED-A fibronectin was confined to perivascular areas in normal conjunctiva but abundantly present in all the scarred filtering blebs. In light of previous studies by other investigators, these data are consistent with TGF-beta-induced alterations and indicate a state of enhanced TGF-beta responsiveness in scarred filtering blebs. A strong TGF-beta receptor expression can result from stimulation by TGF-beta [19,20] and has been demonstrated in subcutaneous fibroblasts of granulation tissue and hypertrophic cutaneous scars [14] as well as in an animal model of excisional wound repair [21]. Furthermore, pronounced TGF-beta receptor expression results in enhanced TGF-beta responses [22]. The sparse staining for TGF-beta-RII in fibroblasts of normal conjunctiva does not exclude TGF-beta receptor expression but rather indicates a low expression level close to the limit of immunofluorescence detection. Human tenon fibroblasts, derived from normal conjunctiva, respond to TGF-beta in vitro [23], and TGF-beta, released during initial wound healing, may well induce increased TGF-beta receptor expression and auto-induction of the cytokine TGF-beta [24], in conjunctival fibroblasts. Our observation of strong TGF-beta receptor expression in subconjunctival fibroblasts of scarred filtering blebs may thus indicate an activated deregulated state of fibroblasts with increased responsiveness to TGF-beta. Moreover, the increased expression of prolyl-4-hydroxlase, an enzyme essential in collagen processing, suggests the activation of most fibroblasts in the scarred filtering blebs. The recent observation that four subconjunctival injections of a monoclonal anti-TGF-beta2 antibody had no effect on postoperative scarring in a phase III clinical trial [9] does not rule out a role of TGF-beta in the scarring process. Our current data and previous studies suggest that the application regimen used in the trial and the concept to distinctly target the TGF-beta2 isoform may deserve some reconsideration.
###end p 39
###begin p 40
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 412 414 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 519 521 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
The role of cell-matrix interactions in shaping the response of tissue cells to extracellular stimuli is increasingly acknowledged [25]. Fibronectin is a central component of the extracellular matrix and serves both as a structural and regulatory element. TGF-beta induces expression of the fibronectin splice variant, ED-A, which is essential for subsequent TGF-beta-induced myofibroblast transdifferentiation [11]. In line with these data, mice deficient for the ED-A fibronectin isoform show impaired wound healing [26]. On the other hand, persistence of activated fibroblasts and ED-A fibronectin is strongly associated with hypertrophic scar formation. It is conceivable that a pronounced TGF-beta receptor expression and the presence of ED-A fibronectin enhance TGF-beta-driven scarring responses in glaucoma revision surgery.
###end p 40
###begin p 41
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
In summary, our data are consistent with an essential role of TGF-beta in human filtering bleb scarring and suggest that specific therapies targeting relevant cell-matrix interactions and TGF-beta signaling may be of particular benefit in our care for patients undergoing revision glaucoma surgery.
###end p 41
###begin title 42
Acknowledgments
###end title 42
###begin p 43
This work was supported by the Interdisziplinares Zentrum fur Klinische Forschung (IZKF), Wurzburg, Germany. We are indebted to Proferssor M. Sendtner and his group at the Institute for Clinical Neurobiology, Wurzburg, Germany for generously sharing advice and equipment.
###end p 43
###begin title 44
References
###end title 44
###begin article-title 45
Myofibroblasts and mechano-regulation of connective tissue remodelling.
###end article-title 45
###begin article-title 46
Transforming growth factor beta in tissue fibrosis.
###end article-title 46
###begin article-title 47
###xml 57 62 <span type="species:ncbi:9606">human</span>
Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.
###end article-title 47
###begin article-title 48
###xml 92 97 <span type="species:ncbi:9606">human</span>
Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye.
###end article-title 48
###begin article-title 49
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
###end article-title 49
###begin article-title 50
Cataract induction in lenses cultured with transforming growth factor-beta.
###end article-title 50
###begin article-title 51
Role of transforming growth factor beta in conjunctival scarring.
###end article-title 51
###begin article-title 52
Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.
###end article-title 52
###begin article-title 53
###xml 37 42 <span type="species:ncbi:9606">human</span>
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.
###end article-title 53
###begin article-title 54
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
###end article-title 54
###begin article-title 55
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.
###end article-title 55
###begin article-title 56
###xml 146 151 <span type="species:ncbi:9606">human</span>
Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts.
###end article-title 56
###begin article-title 57
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery.
###end article-title 57
###begin article-title 58
Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar.
###end article-title 58
###begin article-title 59
Regulation of cell proliferation by Smad proteins.
###end article-title 59
###begin article-title 60
Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways.
###end article-title 60
###begin article-title 61
TGF-beta receptor function in the endothelium.
###end article-title 61
###begin article-title 62
Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality.
###end article-title 62
###begin article-title 63
###xml 57 62 <span type="species:ncbi:9606">human</span>
Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta.
###end article-title 63
###begin article-title 64
Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.
###end article-title 64
###begin article-title 65
RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
###end article-title 65
###begin article-title 66
Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts.
###end article-title 66
###begin article-title 67
###xml 78 83 <span type="species:ncbi:9606">human</span>
p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
###end article-title 67
###begin article-title 68
Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.
###end article-title 68
###begin article-title 69
Tissue cells feel and respond to the stiffness of their substrate.
###end article-title 69
###begin article-title 70
Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan.
###end article-title 70

